Learn the latest findings from IPFNet, SARP and the SCCOR program, and get updates from the Centers for Disease Control and Prevention; the National Heart, Lung, and Blood Institute; and the National Institute of Infectious Diseases during these clinical trial sessions, which will take place from noon to 1 p.m. on Wednesday.
| • | L16: Update from the CDC’s TB Trials Consortium (TBTC) and TB Epidemiologic Studies Consortium (TBESC) (sponsored by the CDC) |
| • | L17: Genes, Biomarkers and Quantitative Traits: Going Beyond Case-Control Studies in the Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Prospective Cohort Studies(sponsored by the NHLBI) |
| • | L18: New U.S. Guidelines for the Diagnosis and Management of Food Allergy (sponsored by the National Institute of Infectious Diseases/NIH) |
| • | L19: Regulation of Flavoring Exposures and Medical Surveillance (sponsored by the National Institute for Occupational Health and Safety) |
| • | L20: Genomics Research: High Throughout Projects Funded by ARRA (sponsored by the NHLBI’s Division of Lung Diseases) |
| • | L21: NHLBI Severe Asthma Research Program (SARP); New Findings (sponsored by the NHLBI’s Division of Lung Diseases) |
| • | L22: Report from the NHLBI Pulmonary Vascular SCCOR Program (sponsored by the NHLBI’s Division of Lung Diseases) |
| • | L23: Idiopathic Pulmonary Fibrosis Network (IPFNet) Update: New Insights into Treatment and Potential New Targets(sponsored by the NHLBI’s Division of Lung Diseases) |
Please see the 2011 ATS Final Program, which includes more information on locations and speakers.